{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:58:11Z","timestamp":1794718691984,"version":"4.9.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110377\/Z\/15\/Z"],"award-info":[{"award-number":["110377\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110377\/Z\/15\/Z"],"award-info":[{"award-number":["110377\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110377\/Z\/15\/Z"],"award-info":[{"award-number":["110377\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110377\/Z\/15\/Z"],"award-info":[{"award-number":["110377\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000304","name":"Parkinson\u2019s UK","doi-asserted-by":"publisher","award":["F-1502"],"award-info":[{"award-number":["F-1502"]}],"id":[{"id":"10.13039\/501100000304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T033428\/01"],"award-info":[{"award-number":["MR\/T033428\/01"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Huntington\u2019s disease (HD) is an inherited neurodegenerative disease. In humans, the clinical diagnosis is often dependent on the emergence of motor symptoms. However, cognitive impairments and metabolic changes can be early indicators. HD mouse models are a useful tool to understand disease progression, however, relatively few studies have monitored the timeline for the emergence of cognitive indices with motor and metabolic phenotypes in parallel. In this study, cognitive, motor, and metabolic phenotypes were investigated at different ages in the zQ175 knock-in mouse alongside immunohistochemical and long-term potentiation (LTP) studies. We demonstrated that zQ175 mice developed impaired hippocampal LTP at 3-months and cognitive deficits in visuospatial attention were evident by 4-months. Long-term and spatial memory impairments emerged by 12-months, alongside motor impairments. Additionally, an anxiolytic-like phenotype emerged at 6-months. Differences in body weight were also detected from 6-months onwards, primarily driven by a reduction in fat mass. Additionally, reduced brain weight and the presence of huntingtin aggregates in the hippocampus, striatum and hypothalamus were observed at 12-months. These data support the zQ175 mouse as a model of HD, which recapitulates many aspects of the disease progression in humans and can be used to understand mechanisms underlying the disease.<\/jats:p>","DOI":"10.1038\/s41598-025-17956-5","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T10:30:35Z","timestamp":1759487435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of cognitive, motor, metabolic, and mutant huntingtin aggregation in the zQ175 mouse model of Huntington\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Fiona H.","family":"McLean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah J.","family":"Lelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanapon","family":"Ekkunagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Rybnicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamund F.","family":"Langston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"6","key":"17956_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald, M. E. et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington\u2019s disease chromosomes. Cell 72 (6), 971\u2013983 (1993).","journal-title":"Cell"},{"issue":"4","key":"17956_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao, M. et al. Trinucleotide repeat length instability and age of onset in huntington\u2019s disease. Nat. Genet. 4 (4), 387\u2013392 (1993).","journal-title":"Nat. Genet."},{"issue":"1","key":"17956_CR3","first-page":"16","volume":"59","author":"DC Rubinsztein","year":"1996","unstructured":"Rubinsztein, D. C. et al. Phenotypic characterization of individuals with 30\u201340 CAG repeats in the huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats. Am. J. Hum. Genet. 59 (1), 16 (1996).","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"17956_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew, S. E. et al. The relationship between trinucleotide (CAG) repeat length and clinical features of huntington\u2019s disease. Nat. Genet. 4 (4), 398\u2013403 (1993).","journal-title":"Nat. Genet."},{"key":"17956_CR5","doi-asserted-by":"crossref","unstructured":"Novak, M. J. & Tabrizi, S. J. Huntington\u2019s disease. Bmj. 340, 30 (2010).","DOI":"10.1136\/bmj.c3109"},{"issue":"8","key":"17956_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","volume":"8","author":"JM van der Burg","year":"2009","unstructured":"van der Burg, J. M., Bj\u00f6rkqvist, M. & Brundin, P. Beyond the brain: widespread pathology in huntington\u2019s disease. Lancet Neurol. 8 (8), 765\u2013774 (2009).","journal-title":"Lancet Neurol."},{"issue":"12","key":"17956_CR7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","volume":"62","author":"K Duff","year":"2007","unstructured":"Duff, K. et al. Psychiatric symptoms in huntington\u2019s disease before diagnosis: the predict-HD study. Biol. Psychiatry. 62 (12), 1341\u20131346 (2007).","journal-title":"Biol. Psychiatry"},{"key":"17956_CR8","doi-asserted-by":"publisher","first-page":"116523","DOI":"10.1016\/j.jns.2019.116523","volume":"408","author":"P Julayanont","year":"2020","unstructured":"Julayanont, P., McFarland, N. R. & Heilman, K. M. Mild cognitive impairment and dementia in motor manifest huntington\u2019s disease: classification and prevalence. J. Neurol. Sci. 408, 116523 (2020).","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"17956_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","volume":"11","author":"JS Paulsen","year":"2011","unstructured":"Paulsen, J. S. Cognitive impairment in huntington disease: diagnosis and treatment. Curr. Neurol. Neurosci. Rep. 11 (5), 474 (2011).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"17956_CR10","unstructured":"Menalled, L. et al. A Field Guide To Working with Mouse Models of Huntington\u2019s Disease (PsychoGenics Inc, The Jackson Laboratory, CHDI Foundation., 2014)."},{"issue":"1","key":"17956_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","volume":"23","author":"LB Menalled","year":"2002","unstructured":"Menalled, L. B. & Chesselet, M-F. Mouse models of huntington\u2019s disease. Trends Pharmacol. Sci. 23 (1), 32\u201339 (2002).","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"17956_CR12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/brain\/awg077","volume":"126","author":"F Squitieri","year":"2003","unstructured":"Squitieri, F. et al. Homozygosity for CAG mutation in huntington disease is associated with a more severe clinical course. Brain 126 (4), 946\u2013955 (2003).","journal-title":"Brain"},{"issue":"1","key":"17956_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled, L. B., Sison, J. D., Dragatsis, I., Zeitlin, S. & Chesselet, M. F. Time course of early motor and neuropathological anomalies in a knock-in mouse model of huntington\u2019s disease with 140 CAG repeats. J. Comp. Neurol. 465 (1), 11\u201326 (2003).","journal-title":"J. Comp. Neurol."},{"issue":"12","key":"17956_CR14","doi-asserted-by":"publisher","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled, L. B. et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of huntington\u2019s disease: zQ175. PloS One. 7 (12), e49838 (2012).","journal-title":"PloS One"},{"issue":"1","key":"17956_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12915-024-01919-9","volume":"22","author":"ET Koch","year":"2024","unstructured":"Koch, E. T. et al. Deep behavioural phenotyping of the Q175 huntington disease mouse model: effects of age, sex, and weight. BMC Biol. 22 (1), 1\u201319 (2024).","journal-title":"BMC Biol."},{"issue":"17","key":"17956_CR16","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1093\/hmg\/ddw212","volume":"25","author":"AL Southwell","year":"2016","unstructured":"Southwell, A. L. et al. An enhanced Q175 knock-in mouse model of huntington disease with higher mutant Huntingtin levels and accelerated disease phenotypes. Hum. Mol. Genet. 25 (17), 3654\u20133675 (2016).","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"17956_CR17","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/brain\/awl082","volume":"129","author":"S Cooke","year":"2006","unstructured":"Cooke, S. & Bliss, T. Plasticity in the human central nervous system. Brain 129 (7), 1659\u20131673 (2006).","journal-title":"Brain"},{"issue":"2","key":"17956_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1534\/genetics.116.195578","volume":"205","author":"JL Neto","year":"2017","unstructured":"Neto, J. L. et al. Genetic contributors to intergenerational CAG repeat instability in huntington\u2019s disease knock-in mice. Genetics 205 (2), 503\u2013516 (2017).","journal-title":"Genetics"},{"issue":"4","key":"17956_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/mp.2012.80","volume":"18","author":"H Zhang","year":"2013","unstructured":"Zhang, H. et al. Regulation of AMPA receptor surface trafficking and synaptic plasticity by a cognitive enhancer and antidepressant molecule. Mol. Psychiatry. 18 (4), 471\u2013484 (2013).","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"17956_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1037\/0735-7044.115.4.799","volume":"115","author":"RD Rogers","year":"2001","unstructured":"Rogers, R. D., Baunez, C., Everitt, B. J. & Robbins, T. W. Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance. Behav. Neurosci. 115 (4), 799 (2001).","journal-title":"Behav. Neurosci."},{"issue":"2\u20133","key":"17956_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.brainresbull.2011.10.019","volume":"88","author":"RC Trueman","year":"2012","unstructured":"Trueman, R. C., Dunnett, S. B., Jones, L. & Brooks, S. P. Five choice serial reaction time performance in the HdhQ92 mouse model of huntington\u2019s disease. Brain Res. Bull. 88 (2\u20133), 163\u2013170 (2012).","journal-title":"Brain Res. Bull."},{"key":"17956_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.expneurol.2016.05.008","volume":"282","author":"E Yhnell","year":"2016","unstructured":"Yhnell, E., Lelos, M. J., Dunnett, S. B. & Brooks, S. P. Cognitive training modifies disease symptoms in a mouse model of huntington\u2019s disease. Exp. Neurol. 282, 19\u201326 (2016).","journal-title":"Exp. Neurol."},{"key":"17956_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.neubiorev.2019.01.015","volume":"98","author":"Y Glikmann-Johnston","year":"2019","unstructured":"Glikmann-Johnston, Y., Fink, K. D., Deng, P., Torrest, A. & Stout, J. C. Spatial memory in huntington\u2019s disease: A comparative review of human and animal data. Neurosci. Biobehavioral Reviews. 98, 194\u2013207 (2019).","journal-title":"Neurosci. Biobehavioral Reviews"},{"issue":"6","key":"17956_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1017\/S1355617716000321","volume":"22","author":"I Labuschagne","year":"2016","unstructured":"Labuschagne, I. et al. Visuospatial processing deficits linked to posterior brain regions in premanifest and early stage huntington\u2019s disease. J. Int. Neuropsychol. Soc. 22 (6), 595\u2013608 (2016).","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"6","key":"17956_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/brainsci7060067","volume":"7","author":"RA Paoli","year":"2017","unstructured":"Paoli, R. A. et al. Neuropsychiatric burden in huntington\u2019s disease. Brain Sci. 7 (6), 67 (2017).","journal-title":"Brain Sci."},{"issue":"1","key":"17956_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nprot.2006.19","volume":"1","author":"RM Deacon","year":"2006","unstructured":"Deacon, R. M. Burrowing in rodents: a sensitive method for detecting behavioral dysfunction. Nat. Protoc. 1 (1), 118\u2013121 (2006).","journal-title":"Nat. Protoc."},{"key":"17956_CR27","doi-asserted-by":"crossref","unstructured":"Deacon, R. Assessing burrowing, nest construction, and hoarding in mice. JoVE (Journal Visualized Experiments), 59, e2607 (2012).","DOI":"10.3791\/2607-v"},{"key":"17956_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fnbeh.2020.00145","volume":"14","author":"M La-Vu","year":"2020","unstructured":"La-Vu, M., Tobias, B. C., Schuette, P. J. & Adhikari, A. To approach or avoid: an introductory overview of the study of anxiety using rodent assays. Front. Behav. Neurosci. 14, 145 (2020).","journal-title":"Front. Behav. Neurosci."},{"issue":"4","key":"17956_CR29","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0091-3057(88)90413-3","volume":"31","author":"D Treit","year":"1988","unstructured":"Treit, D. & Fundytus, M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav. 31 (4), 959\u2013962 (1988).","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"17956_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0166-4328(94)90008-6","volume":"61","author":"P Simon","year":"1994","unstructured":"Simon, P., Dupuis, R. & Costentin, J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav. Brain. Res. 61 (1), 59\u201364 (1994).","journal-title":"Behav. Brain. Res."},{"issue":"9","key":"17956_CR31","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","volume":"59","author":"L Djousse","year":"2002","unstructured":"Djousse, L. et al. Weight loss in early stage of huntington\u2019s disease. Neurology 59 (9), 1325\u20131330 (2002).","journal-title":"Neurology"},{"key":"17956_CR32","doi-asserted-by":"crossref","unstructured":"Furr-Stimming, E. et al. Exploring the Relationship between Brain Atrophy and Clinical Symptoms in Huntington\u2019s Disease (S41. 009) (AAN Enterprises, 2019).","DOI":"10.1212\/WNL.92.15_supplement.S41.009"},{"issue":"1","key":"17956_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","volume":"238","author":"M Arrasate","year":"2012","unstructured":"Arrasate, M. & Finkbeiner, S. Protein aggregates in huntington\u2019s disease. Exp. Neurol. 238 (1), 1\u201311 (2012).","journal-title":"Exp. Neurol."},{"issue":"6","key":"17956_CR34","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1073\/pnas.0915059107","volume":"107","author":"JR Clarke","year":"2010","unstructured":"Clarke, J. R., Cammarota, M., Gruart, A., Izquierdo, I. & Delgado-Garc\u00eda, J. M. Plastic modifications induced by object recognition memory processing. Proc. Natl. Acad. Sci. 107 (6), 2652\u20132657 (2010).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"17956_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0166-4328(01)00451-X","volume":"133","author":"RM Deacon","year":"2002","unstructured":"Deacon, R. M., Bannerman, D. M., Kirby, B. P., Croucher, A. & Rawlins, J. N. P. Effects of cytotoxic hippocampal lesions in mice on a cognitive test battery. Behav. Brain. Res. 133 (1), 57\u201368 (2002).","journal-title":"Behav. Brain. Res."},{"key":"17956_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00213-002-1154-7","volume":"163","author":"T Robbins","year":"2002","unstructured":"Robbins, T. The 5-choice serial reaction time task: behavioural Pharmacology and functional neurochemistry. Psychopharmacology 163, 362\u2013380 (2002).","journal-title":"Psychopharmacology"},{"key":"17956_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cortex.2019.07.014","volume":"119","author":"KL Harris","year":"2019","unstructured":"Harris, K. L. et al. Huntington\u2019s disease patients display progressive deficits in hippocampal-dependent cognition during a task of Spatial memory. Cortex 119, 417\u2013427 (2019).","journal-title":"Cortex"},{"issue":"5","key":"17956_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archneur.56.5.563","volume":"56","author":"SC Kirkwood","year":"1999","unstructured":"Kirkwood, S. C. et al. Longitudinal cognitive and motor changes among presymptomatic huntington disease gene carriers. Arch. Neurol. 56 (5), 563\u2013568 (1999).","journal-title":"Arch. Neurol."},{"issue":"1","key":"17956_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/jnnp.74.1.120","volume":"74","author":"J Hamilton","year":"2003","unstructured":"Hamilton, J. et al. Behavioural abnormalities contribute to functional decline in huntington\u2019s disease. J. Neurol. Neurosurg. Psychiatry. 74 (1), 120\u2013122 (2003).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"13","key":"17956_CR40","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","volume":"20","author":"KP Murphy","year":"2000","unstructured":"Murphy, K. P. et al. Abnormal synaptic plasticity and impaired Spatial cognition in mice Transgenic for exon 1 of the human huntington\u2019s disease mutation. J. Neurosci. 20 (13), 5115\u20135123 (2000).","journal-title":"J. Neurosci."},{"issue":"2\u20133","key":"17956_CR41","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.brainresbull.2006.10.018","volume":"72","author":"JM Van Raamsdonk","year":"2007","unstructured":"Van Raamsdonk, J. M., Warby, S. C. & Hayden, M. R. Selective degeneration in YAC mouse models of huntington disease. Brain Res. Bull. 72 (2\u20133), 124\u2013131 (2007).","journal-title":"Brain Res. Bull."},{"issue":"16","key":"17956_CR42","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","volume":"25","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk, J. M. et al. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of huntington\u2019s disease. J. Neurosci. 25 (16), 4169\u20134180 (2005).","journal-title":"J. Neurosci."},{"issue":"2\u20133","key":"17956_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.brainresbull.2010.05.003","volume":"88","author":"S Brooks","year":"2012","unstructured":"Brooks, S., Higgs, G., Jones, L. & Dunnett, S. B. Longitudinal analysis of the behavioural phenotype in HdhQ92 huntington\u2019s disease knock-in mice. Brain Res. Bull. 88 (2\u20133), 148\u2013155 (2012).","journal-title":"Brain Res. Bull."},{"issue":"10","key":"17956_CR44","doi-asserted-by":"publisher","first-page":"e0164072","DOI":"10.1371\/journal.pone.0164072","volume":"11","author":"E Yhnell","year":"2016","unstructured":"Yhnell, E., Dunnett, S. B. & Brooks, S. P. A longitudinal operant assessment of cognitive and behavioural changes in the HdhQ111 mouse model of huntington\u2019s disease. PloS One. 11 (10), e0164072 (2016).","journal-title":"PloS One"},{"issue":"510","key":"17956_CR45","doi-asserted-by":"publisher","first-page":"eaan6387","DOI":"10.1126\/scisignal.aan6387","volume":"10","author":"KS Abd-Elrahman","year":"2017","unstructured":"Abd-Elrahman, K. S. et al. mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of huntington\u2019s disease. Sci. Signal. 10 (510), eaan6387 (2017).","journal-title":"Sci. Signal."},{"issue":"1","key":"17956_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos, R. A. Huntington\u2019s disease: a clinical review. Orphanet J. Rare Dis. 5 (1), 1\u20138 (2010).","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"17956_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neubiorev.2004.03.004","volume":"28","author":"D Bannerman","year":"2004","unstructured":"Bannerman, D. et al. Regional dissociations within the hippocampus\u2014memory and anxiety. Neurosci. Biobehavioral Reviews. 28 (3), 273\u2013283 (2004).","journal-title":"Neurosci. Biobehavioral Reviews"},{"key":"17956_CR48","doi-asserted-by":"crossref","unstructured":"Kjelstrup, K. G. et al. Reduced fear expression after lesions of the ventral hippocampus. Proceedings of the National Academy of Sciences. ;99(16):10825-30. (2002).","DOI":"10.1073\/pnas.152112399"},{"issue":"1\u20132","key":"17956_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0006-8993(98)00736-7","volume":"805","author":"SE File","year":"1998","unstructured":"File, S. E., Mahal, A., Mangiarini, L. & Bates, G. P. Striking changes in anxiety in huntington\u2019s disease Transgenic mice. Brain Res. 805 (1\u20132), 234\u2013240 (1998).","journal-title":"Brain Res."},{"issue":"2","key":"17956_CR50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nbd.2011.04.009","volume":"43","author":"AG Walker","year":"2011","unstructured":"Walker, A. G., Ummel, J. R. & Rebec, G. V. Reduced expression of conditioned fear in the R6\/2 mouse model of huntington\u2019s disease is related to abnormal activity in prelimbic cortex. Neurobiol. Dis. 43 (2), 379\u2013387 (2011).","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"17956_CR51","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","volume":"157","author":"MA Hickey","year":"2008","unstructured":"Hickey, M. A. et al. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in huntington\u2019s disease mice. Neuroscience 157 (1), 280\u2013295 (2008).","journal-title":"Neuroscience"},{"issue":"2","key":"17956_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neulet.2011.11.063","volume":"507","author":"S Orvoen","year":"2012","unstructured":"Orvoen, S., Pla, P., Gardier, A. M., Saudou, F. & David, D. J. Huntington\u2019s disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation. Neurosci. Lett. 507 (2), 127\u2013132 (2012).","journal-title":"Neurosci. Lett."},{"issue":"11","key":"17956_CR53","doi-asserted-by":"publisher","first-page":"e80923","DOI":"10.1371\/journal.pone.0080923","volume":"8","author":"SM H\u00f6lter","year":"2013","unstructured":"H\u00f6lter, S. M. et al. A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in huntington\u2019s disease CAG knock-in mice. PloS One. 8 (11), e80923 (2013).","journal-title":"PloS One"},{"issue":"8","key":"17956_CR54","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter, R. J. et al. Characterization of progressive motor deficits in mice Transgenic for the human huntington\u2019s disease mutation. J. Neurosci. 19 (8), 3248\u20133257 (1999).","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"17956_CR55","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","volume":"126","author":"H-G L\u00fcesse","year":"2001","unstructured":"L\u00fcesse, H-G. et al. Evaluation of R6\/2 HD Transgenic mice for therapeutic studies in huntington\u2019s disease: behavioral testing and impact of diabetes mellitus. Behav. Brain. Res. 126 (1\u20132), 185\u2013195 (2001).","journal-title":"Behav. Brain. Res."},{"issue":"13","key":"17956_CR56","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow, E. J. et al. Selective striatal neuronal loss in a YAC128 mouse model of huntington disease. Hum. Mol. Genet. 12 (13), 1555\u20131567 (2003).","journal-title":"Hum. Mol. Genet."},{"issue":"24","key":"17956_CR57","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray, M. et al. Full-length human mutant Huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J. Neurosci. 28 (24), 6182\u20136195 (2008).","journal-title":"J. Neurosci."},{"key":"17956_CR58","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bbr.2012.10.039","volume":"238","author":"KA Yah-se","year":"2013","unstructured":"Yah-se, K. A., Schreiber, R. & Ellenbroek, B. Motor, emotional and cognitive deficits in adult BACHD mice: a model for huntington\u2019s disease. Behav. Brain. Res. 238, 243\u2013251 (2013).","journal-title":"Behav. Brain. Res."},{"issue":"2","key":"17956_CR59","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/JHD-160191","volume":"5","author":"E Yhnell","year":"2016","unstructured":"Yhnell, E., Dunnett, S. B. & Brooks, S. P. A longitudinal motor characterisation of the Hdh Q111 mouse model of huntington\u2019s disease. J. Huntington\u2019s Disease. 5 (2), 149\u2013161 (2016).","journal-title":"J. Huntington\u2019s Disease"},{"issue":"3","key":"17956_CR60","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.nbd.2010.07.013","volume":"40","author":"C Soneson","year":"2010","unstructured":"Soneson, C. et al. Early changes in the hypothalamic region in prodromal huntington disease revealed by MRI analysis. Neurobiol. Dis. 40 (3), 531\u2013543 (2010).","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"17956_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","volume":"29","author":"JM van der Burg","year":"2008","unstructured":"van der Burg, J. M. et al. Increased metabolism in the R6\/2 mouse model of huntington\u2019s disease. Neurobiol. Dis. 29 (1), 41\u201351 (2008).","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"17956_CR62","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","volume":"48","author":"MS Hurlbert","year":"1999","unstructured":"Hurlbert, M. S. et al. Mice Transgenic for an expanded CAG repeat in the huntington\u2019s disease gene develop diabetes. Diabetes 48 (3), 649\u2013651 (1999).","journal-title":"Diabetes"},{"issue":"11","key":"17956_CR63","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/brain\/awm217","volume":"130","author":"A Feigin","year":"2007","unstructured":"Feigin, A. et al. Thalamic metabolism and symptom onset in preclinical huntington\u2019s disease. Brain 130 (11), 2858\u20132867 (2007).","journal-title":"Brain"},{"issue":"6","key":"17956_CR64","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","volume":"119","author":"A Antonini","year":"1996","unstructured":"Antonini, A. et al. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with huntington\u2019s disease. Brain 119 (6), 2085\u20132095 (1996).","journal-title":"Brain"},{"issue":"9","key":"17956_CR65","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/jcbfm.2014.110","volume":"34","author":"L Boussicault","year":"2014","unstructured":"Boussicault, L. et al. Impaired brain energy metabolism in the BACHD mouse model of huntington\u2019s disease: critical role of astrocyte\u2013neuron interactions. J. Cereb. Blood Flow. Metabolism. 34 (9), 1500\u20131510 (2014).","journal-title":"J. Cereb. Blood Flow. Metabolism"},{"issue":"9557","key":"17956_CR66","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker, F. O. Huntington\u2019s disease. Lancet 369 (9557), 218\u2013228 (2007).","journal-title":"Lancet"},{"key":"17956_CR67","doi-asserted-by":"crossref","unstructured":"Reiner, A., Dragatsis, I. & Dietrich, P. Genetics and neuropathology of Huntington\u2019s disease. International review of neurobiology. 98: Elsevier; pp. 325\u2009\u2013\u200972. (2011).","DOI":"10.1016\/B978-0-12-381328-2.00014-6"},{"issue":"21","key":"17956_CR68","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1093\/hmg\/ddl394","volume":"15","author":"HP Nguyen","year":"2006","unstructured":"Nguyen, H. P. et al. Behavioral abnormalities precede neuropathological markers in rats Transgenic for huntington\u2019s disease. Hum. Mol. Genet. 15 (21), 3177\u20133194 (2006).","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"17956_CR69","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bbr.2008.01.020","volume":"189","author":"RC Trueman","year":"2008","unstructured":"Trueman, R. C., Brooks, S. P., Jones, L. & Dunnett, S. B. Time course of choice reaction time deficits in the HdhQ92 knock-in mouse model of huntington\u2019s disease in the operant serial implicit learning task (SILT). Behav. Brain. Res. 189 (2), 317\u2013324 (2008).","journal-title":"Behav. Brain. Res."},{"key":"17956_CR70","doi-asserted-by":"crossref","unstructured":"Smith, E. J. et al. Early detection of exon 1 Huntingtin aggregation in zQ175 brains by molecular and histological approaches. Brain Commun. 5(1), (2023).","DOI":"10.1093\/braincomms\/fcad010"},{"issue":"5","key":"17956_CR71","doi-asserted-by":"publisher","first-page":"e0155834","DOI":"10.1371\/journal.pone.0155834","volume":"11","author":"Z Bayram-Weston","year":"2016","unstructured":"Bayram-Weston, Z., Jones, L., Dunnett, S. B. & Brooks, S. P. Comparison of mHTT antibodies in huntington\u2019s disease mouse models reveal specific binding profiles and steady-state ubiquitin levels with disease development. PLoS One. 11 (5), e0155834 (2016).","journal-title":"PLoS One"},{"issue":"6073","key":"17956_CR72","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1126\/science.1214956","volume":"335","author":"A Mar\u00edn-Burgin","year":"2012","unstructured":"Mar\u00edn-Burgin, A., Mongiat, L. A., Pardi, M. B. & Schinder, A. F. Unique processing during a period of high excitation\/inhibition balance in adult-born neurons. Science 335 (6073), 1238\u20131242 (2012).","journal-title":"Science"},{"issue":"3","key":"17956_CR73","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/jnen\/62.3.272","volume":"62","author":"W Maxwell","year":"2003","unstructured":"Maxwell, W. et al. There is differential loss of pyramidal cells from the human hippocampus with survival after blunt head injury. J. Neuropathology Experimental Neurol. 62 (3), 272\u2013279 (2003).","journal-title":"J. Neuropathology Experimental Neurol."},{"issue":"2","key":"17956_CR74","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/jnen\/73.2.136","volume":"73","author":"KJ Hatanpaa","year":"2014","unstructured":"Hatanpaa, K. J. et al. Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields. J. Neuropathology Experimental Neurol. 73 (2), 136\u2013142 (2014).","journal-title":"J. Neuropathology Experimental Neurol."},{"issue":"4","key":"17956_CR75","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/cercor\/bhz245","volume":"30","author":"EJ Donzis","year":"2020","unstructured":"Donzis, E. J. et al. Cortical network dynamics is altered in mouse models of huntington\u2019s disease. Cereb. Cortex. 30 (4), 2372\u20132388 (2020).","journal-title":"Cereb. Cortex"},{"issue":"10","key":"17956_CR76","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1523\/JNEUROSCI.0782-21.2022","volume":"42","author":"JW Callahan","year":"2022","unstructured":"Callahan, J. W., Wokosin, D. L. & Bevan, M. D. Dysregulation of the basal ganglia indirect pathway in early symptomatic Q175 huntington\u2019s disease mice. J. Neurosci. 42 (10), 2080\u20132102 (2022).","journal-title":"J. Neurosci."},{"key":"17956_CR77","doi-asserted-by":"publisher","first-page":"e21616","DOI":"10.7554\/eLife.21616","volume":"5","author":"JF Atherton","year":"2016","unstructured":"Atherton, J. F. et al. Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of huntington\u2019s disease. Elife 5, e21616 (2016).","journal-title":"Elife"},{"key":"17956_CR78","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.nbd.2017.05.011","volume":"105","author":"I Sebastianutto","year":"2017","unstructured":"Sebastianutto, I., Cenci, M. A. & Fieblinger, T. Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of huntington\u2019s disease. Neurobiol. Dis. 105, 117\u2013131 (2017).","journal-title":"Neurobiol. Dis."},{"issue":"16","key":"17956_CR79","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","volume":"27","author":"G Lynch","year":"2007","unstructured":"Lynch, G. et al. Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of huntington\u2019s disease. J. Neurosci. 27 (16), 4424\u20134434 (2007).","journal-title":"J. Neurosci."},{"issue":"1","key":"17956_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"H Zhang","year":"2018","unstructured":"Zhang, H. et al. Modulation of AMPA receptor surface diffusion restores hippocampal plasticity and memory in huntington\u2019s disease models. Nat. Commun. 9 (1), 1\u201316 (2018).","journal-title":"Nat. Commun."},{"issue":"5","key":"17956_CR81","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/brain\/awae063","volume":"147","author":"SG Aldous","year":"2024","unstructured":"Aldous, S. G. et al. A CAG repeat threshold for therapeutics targeting somatic instability in huntington\u2019s disease. Brain 147 (5), 1784\u20131798 (2024).","journal-title":"Brain"},{"issue":"2","key":"17956_CR82","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1152\/jn.00762.2011","volume":"107","author":"DM Cummings","year":"2012","unstructured":"Cummings, D. M. et al. A critical window of CAG repeat-length correlates with phenotype severity in the R6\/2 mouse model of huntington\u2019s disease. J. Neurophysiol. 107 (2), 677\u2013691 (2012).","journal-title":"J. Neurophysiol."},{"issue":"3","key":"17956_CR83","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","volume":"33","author":"AJ Morton","year":"2009","unstructured":"Morton, A. J. et al. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice. Neurobiol. Dis. 33 (3), 331\u2013341 (2009).","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"17956_CR84","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.nbd.2008.10.009","volume":"33","author":"I Dragatsis","year":"2009","unstructured":"Dragatsis, I. et al. CAG repeat lengths\u2009\u2265\u2009335 attenuate the phenotype in the R6\/2 huntington\u2019s disease Transgenic mouse. Neurobiol. Dis. 33 (3), 315\u2013330 (2009).","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"17956_CR85","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1083\/jcb.141.5.1097","volume":"141","author":"AS Hackam","year":"1998","unstructured":"Hackam, A. S. et al. The influence of Huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141 (5), 1097\u20131105 (1998).","journal-title":"J. Cell Biol."},{"issue":"15","key":"17956_CR86","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/hmg\/ddh175","volume":"13","author":"G Schilling","year":"2004","unstructured":"Schilling, G. et al. Nuclear-targeting of mutant Huntingtin fragments produces huntington\u2019s disease-like phenotypes in Transgenic mice. Hum. Mol. Genet. 13 (15), 1599\u20131610 (2004).","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"17956_CR87","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/hmg\/8.5.763","volume":"8","author":"PF Shelbourne","year":"1999","unstructured":"Shelbourne, P. F. et al. A huntington\u2019s disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum. Mol. Genet. 8 (5), 763\u2013774 (1999).","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"17956_CR88","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13041-023-01054-6","volume":"16","author":"SH Li","year":"2023","unstructured":"Li, S. H., Colson, T-L-L., Chen, J., Abd-Elrahman, K. S. & Ferguson, S. S. Comparison of huntington\u2019s disease phenotype progression in male and female heterozygous FDNQ175 mice. Mol. Brain. 16 (1), 67 (2023).","journal-title":"Mol. Brain"},{"key":"17956_CR89","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3389\/fneur.2020.00571","volume":"11","author":"D Zielonka","year":"2020","unstructured":"Zielonka, D. & Stawinska-Witoszynska, B. Gender differences in non-sex linked disorders: insights from huntington\u2019s disease. Front. Neurol. 11, 571 (2020).","journal-title":"Front. Neurol."},{"issue":"17","key":"17956_CR90","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","volume":"17","author":"FJ Bode","year":"2008","unstructured":"Bode, F. J. et al. Sex differences in a Transgenic rat model of huntington\u2019s disease: decreased 17\u03b2-estradiol levels correlate with reduced numbers of DARPP32\u2009+\u2009neurons in males. Hum. Mol. Genet. 17 (17), 2595\u20132609 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"17956_CR91","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2014.03.010","volume":"259","author":"KM Smith","year":"2014","unstructured":"Smith, K. M. & Dahodwala, N. Sex differences in parkinson\u2019s disease and other movement disorders. Exp. Neurol. 259, 44\u201356 (2014).","journal-title":"Exp. Neurol."},{"issue":"3","key":"17956_CR92","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/mdc3.13178","volume":"8","author":"S Hentosh","year":"2021","unstructured":"Hentosh, S. et al. Sex differences in huntington\u2019s disease: evaluating the enroll-HD database. Mov. Disorders Clin. Pract. 8 (3), 420\u2013426 (2021).","journal-title":"Mov. Disorders Clin. Pract."},{"issue":"2","key":"17956_CR93","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","volume":"19","author":"D Zielonka","year":"2013","unstructured":"Zielonka, D. et al. The influence of gender on phenotype and disease progression in patients with huntington\u2019s disease. Parkinsonism Relat. Disord. 19 (2), 192\u2013197 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"12","key":"17956_CR94","doi-asserted-by":"publisher","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen, T. et al. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of huntington\u2019s disease. PloS One. 7 (12), e50717 (2012).","journal-title":"PloS One"},{"issue":"4","key":"17956_CR95","doi-asserted-by":"publisher","first-page":"e0123527","DOI":"10.1371\/journal.pone.0123527","volume":"10","author":"N Carty","year":"2015","unstructured":"Carty, N. et al. Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of huntington\u00b4 s disease: an in vivo High-Content imaging study. PLoS One. 10 (4), e0123527 (2015).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17956-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T23:04:20Z","timestamp":1759878260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17956-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17956"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17956-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34563"}}